San Francisco, CA, United States of America

Mallika Singh

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2013)
  • San Francisco, CA (US) (2012 - 2023)
  • Redwood City, CA (US) (2023)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mallika Singh: Innovator in Cancer Treatment

Introduction

Mallika Singh is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of cancer treatment, holding a total of 6 patents. Her innovative approaches focus on utilizing mTOR inhibitors and Ras inhibitors to combat various forms of cancer.

Latest Patents

One of her latest patents involves methods of treating cancer with an mTOR inhibitor. This patent outlines methods for treating diseases or disorders, specifically cancer, by administering a particular dosage of an mTOR inhibitor. Additionally, it includes strategies for delaying, preventing, or treating acquired resistance to RAS inhibitors using an mTOR inhibitor. Another notable patent features macrocyclic compounds and pharmaceutical compositions capable of inhibiting Ras proteins, which are essential in the treatment of cancers.

Career Highlights

Throughout her career, Mallika has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and Revolution Medicines, Inc. Her work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Mallika has collaborated with several professionals in her field, including Marcia Belvin and Lori Friedman. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Mallika Singh's contributions to cancer treatment through her patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…